Literature DB >> 32876704

Corticospinal tract involvement in spinocerebellar ataxia type 3: a diffusion tensor imaging study.

Bruno Shigueo Yonekura Inada1,2, Thiago Junqueira Ribeiro Rezende3, Fernando Vieira Pereira4, Lucas Ávila Lessa Garcia5, Antônio José da Rocha6, Pedro Braga Neto7,8, Orlando Graziani Povoas Barsottini4, Marcondes Cavalcante França3, José Luiz Pedroso4.   

Abstract

PURPOSE: The aim of this study was to evaluate the integrity of the corticospinal tracts (CST) in patients with SCA3 and age- and gender-matched healthy control subjects using diffusion tensor imaging (DTI). We also looked at the clinical correlates of such diffusivity abnormalities.
METHODS: We assessed 2 cohorts from different Brazilian centers: cohort 1 (n = 29) scanned in a 1.5 T magnet and cohort 2 (n = 91) scanned in a 3.0 T magnet. We used Pearson's coefficients to assess the correlation of CST DTI parameters and ataxia severity (expressed by SARA scores).
RESULTS: Two different results were obtained. Cohort 1 showed no significant between-group differences in DTI parameters. Cohort 2 showed significant between-group differences in the FA values in the bilateral precentral gyri (p < 0.001), bilateral superior corona radiata (p < 0.001), bilateral posterior limb of the internal capsule (p < 0.001), bilateral cerebral peduncle (p < 0.001), and bilateral basis pontis (p < 0.001). There was moderate correlation between CST diffusivity parameters and SARA scores in cohort 2 (Pearson correlation coefficient: 0.40-0.59).
CONCLUSION: DTI particularly at 3 T is able to uncover and quantify CST damage in SCA3. Moreover, CST microstructural damage may contribute with ataxia severity in the disease.

Entities:  

Keywords:  Cerebellar ataxia; Corticospinal tract; Diffusion tensor imaging; Machado-Joseph disease; Retrograde degeneration; Spinocerebellar ataxia type 3

Year:  2020        PMID: 32876704     DOI: 10.1007/s00234-020-02528-3

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  31 in total

1.  Cerebral cortex involvement in Machado-Joseph disease.

Authors:  T J R de Rezende; A D'Abreu; R P Guimarães; T M Lopes; I Lopes-Cendes; F Cendes; G Castellano; M C França
Journal:  Eur J Neurol       Date:  2014-09-23       Impact factor: 6.089

2.  Machado disease. A hereditary ataxia in Portuguese emigrants to Massachusetts.

Authors:  K K Nakano; D M Dawson; A Spence
Journal:  Neurology       Date:  1972-01       Impact factor: 9.910

3.  Characteristic magnetic resonance imaging findings in Machado-Joseph disease.

Authors:  Y Murata; S Yamaguchi; H Kawakami; Y Imon; H Maruyama; T Sakai; T Kazuta; T Ohtake; M Nishimura; T Saida; S Chiba; T Oh-i; S Nakamura
Journal:  Arch Neurol       Date:  1998-01

4.  Progressive atrophy of cerebellum and brainstem as a function of age and the size of the expanded CAG repeats in the MJD1 gene in Machado-Joseph disease.

Authors:  O Onodera; J Idezuka; S Igarashi; Y Takiyama; K Endo; H Takano; M Oyake; H Tanaka; T Inuzuka; T Hayashi; T Yuasa; J Ito; T Miyatake; S Tsuji
Journal:  Ann Neurol       Date:  1998-03       Impact factor: 10.422

5.  CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1.

Authors:  Y Kawaguchi; T Okamoto; M Taniwaki; M Aizawa; M Inoue; S Katayama; H Kawakami; S Nakamura; M Nishimura; I Akiguchi
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

Review 6.  Nonmotor and extracerebellar features in Machado-Joseph disease: a review.

Authors:  José Luiz Pedroso; Marcondes C França; Pedro Braga-Neto; Anelyssa D'Abreu; Maria Luiza Saraiva-Pereira; Jonas A Saute; Hélio A Teive; Paulo Caramelli; Laura Bannach Jardim; Iscia Lopes-Cendes; Orlando Graziani P Barsottini
Journal:  Mov Disord       Date:  2013-06-17       Impact factor: 10.338

Review 7.  SCA3: neurological features, pathogenesis and animal models.

Authors:  Olaf Riess; Udo Rüb; Annalisa Pastore; Peter Bauer; Ludger Schöls
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

8.  Motor cortical dysfunction develops in spinocerebellar ataxia type 3.

Authors:  Michelle A Farrar; Steve Vucic; Garth Nicholson; Matthew C Kiernan
Journal:  Clin Neurophysiol       Date:  2016-09-15       Impact factor: 3.708

Review 9.  New insights into the pathoanatomy of spinocerebellar ataxia type 3 (Machado-Joseph disease).

Authors:  Udo Rüb; Ewout R Brunt; Thomas Deller
Journal:  Curr Opin Neurol       Date:  2008-04       Impact factor: 5.710

10.  Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features.

Authors:  A Dürr; G Stevanin; G Cancel; C Duyckaerts; N Abbas; O Didierjean; H Chneiweiss; A Benomar; O Lyon-Caen; J Julien; M Serdaru; C Penet; Y Agid; A Brice
Journal:  Ann Neurol       Date:  1996-04       Impact factor: 10.422

View more
  2 in total

1.  Magnetic Resonance Imaging and Its Clinical Correlation in Spinocerebellar Ataxia Type 3: A Systematic Review.

Authors:  Kah Hui Yap; Hanani Abdul Manan; Noorazrul Yahya; Shahrul Azmin; Shahizon Azura Mohamed Mukari; Norlinah Mohamed Ibrahim
Journal:  Front Neurosci       Date:  2022-06-10       Impact factor: 5.152

2.  Impaired Oligodendrocyte Maturation Is an Early Feature in SCA3 Disease Pathogenesis.

Authors:  Kristen H Schuster; Annie J Zalon; Hongjiu Zhang; Danielle M DiFranco; Nicholas R Stec; Zaid Haque; Kate G Blumenstein; Amanda M Pierce; Yuanfang Guan; Henry L Paulson; Hayley S McLoughlin
Journal:  J Neurosci       Date:  2022-01-18       Impact factor: 6.709

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.